Compare CVS Health Corp (CVS) vs Southern Copper Corp (SCCO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Southern Copper Corp — how do they compare? CVS Health Corp trades at $93.7 (market cap $122.36B), while Southern Copper Corp trades at $194 (market cap $166.96B). The key difference: Southern Copper Corp is the larger of the two by market cap, and CVS Health Corp pays the higher dividend (2.78%). Which is the better fit depends on your goals.
| CVS | SCCO | |
|---|---|---|
Market Cap | $122.36B | $166.96B |
Sector | Health | Basic Materials |
52-Week High | $110.60 | $218.85 |
52-Week Low | $65.51 | $93.70 |
Enterprise Value | $184.71B | $168.25B |
Dividend Yield | 2.78% | 2.23% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $95.70, down 0.54% on the day, with a bearish technical signal and key support at $95. The company reported strong Q2 2026 earnings, beating estimates with EPS of $2.58 versus $1.87 expected, and raised its full-year guidance. Revenue growth remains robust, reaching $402.07 billion in 2025, though net income margin compressed to 1.18%. Analyst sentiment is overwhelmingly positive with a consensus price target of $115.00.
The outlook for CVS is cautiously optimistic, driven by operational improvements in its Aetna segment and raised cash flow guidance. Investment opportunities include potential upside to the consensus target, but risks involve margin pressures, regulatory changes impacting pharmacy benefits in 2027, and high debt levels. The stock's current valuation at a P/E of 25.25 may limit near-term gains if earnings growth slows.
Southern Copper (SCCO) trades at $199.06, up 3.12% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with Q2 2026 EPS beating expectations at $2.01 vs. $1.98, revenue growth from $13.42B in 2025 to projected $15.8B in 2026, and exceptional profitability with 35.87% net margin. Recent corporate actions include dividends and stock splits, while institutional activity shows increased positions from Dimensional Fund Advisors and CalPERS.
SCCO presents growth potential driven by strong earnings performance and AI-driven copper demand, but faces risks from analyst skepticism (41.38% sell ratings) and valuation concerns with P/E of 29.51. The stock trades above consensus price target of $153.64, suggesting limited near-term upside despite positive technical momentum and fundamental strength.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Southern Copper Corp
Southern Copper Corp is an integrated producer of copper and other minerals and operates the mining, smelting, and refining facilities in Peru and Mexico. Its production includes copper, molybdenum, zinc, and silver. The company operates through the following segments: Peruvian operations, Mexican open-pit operations, and Mexican underground mining operations. Southern Copper generates the majority of its revenue from the sale of copper and the rest from the sale of non-copper products, such as molybdenum, silver, zinc, lead, and gold. Its geographical segments are The Americas, Europe, and Asia.
Read more on SCCO →
